Results of production tests

Our medications can be used in the treatment of the large number of diseases: gastrointestinal

tract, urogenital pathways, skin, ear. Combination therapy is possible, including the use of the

drug and any antibacterial agent.

Results of
tests

Our medications can be used in the treatment of the large number of diseases: gastrointestinal

tract, urogenital pathways, skin, ear. Combination therapy is possible, including the use of the

drug and any antibacterial agent.

Results of production tests

Our medications can be used in the treatment of the large number of diseases: gastrointestinal

tract, urogenital pathways, skin, ear. Combination therapy is possible, including the use of the

drug and any antibacterial agent.

Our medications can be used in the treatment of the large number of diseases:

gastrointestinal tract, urogenital pathways, skin, ear. Combination therapy is possible,

including the use of the drug and any antibacterial agent.

Results of Rezovet®

The obtained results of the study of the use of Rezovet in production conditions give grounds for its use as an effective tool for the prevention and treatment of such bacterial infections as: hemophilosis, colibacillosis, mycoplasmosis, pasteurellosis, pullorosis, necrotic enteritis, salmonellosis and its use in the standard scheme of poultry rearing.

The obtained results of the study of the use of Rezovet in production conditions give grounds for its use as an effective tool for the prevention and treatment of such bacterial infections as: hemophilosis, colibacillosis, mycoplasmosis, pasteurellosis, pullorosis, necrotic enteritis, salmonellosis and its use in the standard scheme of poultry rearing.

Results of production tests

Our medications can be used in the treatment of the large number of diseases:

gastrointestinal tract, urogenital pathways, skin, ear. Combination therapy is possible,

including the use of the drug and any antibacterial agent.

Results of Rezovet®

The obtained results of the study of the use of Rezovet in production conditions give grounds for its use as an effective tool for the prevention and treatment of such bacterial infections as: hemophilosis, colibacillosis, mycoplasmosis, pasteurellosis, pullorosis, necrotic enteritis, salmonellosis and its use in the standard scheme of poultry rearing.

Advantages of Rezovet®

Advantages of Rezovet®

There is no waiting period after use

There is no waiting period after use

It does not require a high concentration
of DV in the center of infection

It does not require a high concentration
of DV in the center of infection

It does not affect the properties of meat

It does not affect the properties of meat

High degree and speed of normalization
of the gastrointestinal tract

High degree and speed of normalization
of the gastrointestinal tract

It can be used in prevention and treatment

It can be used in prevention and treatment

Safe. Completely excreted naturally

Safe. Completely excreted naturally

All DVs are allowed for medical use

All DVs are allowed for medical use

The long-term effect of the drug

The long-term effect of the drug

Rezovet® can completely replace antibiotic therapy or reduce it by at least 100 times.

Rezovet® can completely replace antibiotic therapy or reduce it by at least 100 times.

Innovative technology
solution

Innovative technology
solution

Innovative technology
solution

It refers to drugs with a pronounced antibacterial effect against pathogenic strains Staphylococcus aureus, Streptococcus spp., Klebsiella spp., Arcanobacterium pyogenes, Escherichia coli, Ps. aeruginosa. Using as active substances (DV) synthetic analogues of microbial regulatory molecules, allows to suppress the pathogenicity and proliferative activity of bacteria, without resorting to the principle of direct destruction of the bacterium.

It refers to drugs with a pronounced antibacterial effect against pathogenic strains Staphylococcus aureus, Streptococcus spp., Klebsiella spp., Arcanobacterium pyogenes, Escherichia coli, Ps. aeruginosa. Using as active substances (DV) synthetic analogues of microbial regulatory molecules, allows to suppress the pathogenicity and proliferative activity of bacteria, without resorting to the principle of direct destruction of the bacterium.

It refers to drugs with a pronounced antibacterial effect against pathogenic strains Staphylococcus aureus, Streptococcus spp., Klebsiella spp., Arcanobacterium pyogenes, Escherichia coli, Ps. aeruginosa. Using as active substances (DV) synthetic analogues of microbial regulatory molecules, allows to suppress the pathogenicity and proliferative activity of bacteria, without resorting to the principle of direct destruction of the bacterium.

Stimulates the immune
response and reaction

Stimulates the immune
response and reaction

Stimulates the immune
response and reaction

The chemical formula also includes DV, modulating the immune response and cell response to the introduction of pathogen bacteria, which allows to block the pro-inflammatory functions of neutrophils, to increase local immunity, which leads to rapid sanitization of the body and the arresting of inflammatory response. Currently, the drug Rezovet® to include it in the “scheme” of growing poultry as a component of feed has been developed and tested.

The chemical formula also includes DV, modulating the immune response and cell response to the introduction of pathogen bacteria, which allows to block the pro-inflammatory functions of neutrophils, to increase local immunity, which leads to rapid sanitization of the body and the arresting of inflammatory response. Currently, the drug Rezovet® to include it in the “scheme” of growing poultry as a component of feed has been developed and tested.

The chemical formula also includes DV, modulating the immune response and cell response to the introduction of pathogen bacteria, which allows to block the pro-inflammatory functions of neutrophils, to increase local immunity, which leads to rapid sanitization of the body and the arresting of inflammatory response. Currently, the drug Rezovet® to include it in the “scheme” of growing poultry as a component of feed has been developed and tested.

Production of Rezovet®

Production of Rezovet®

The production process of Rezovet® involves a comprehensive and meticulous series of steps to ensure the highest quality and efficacy of the final product.


Stable Therapeutic Efficacy

Stable Therapeutic Efficacy

Stable Therapeutic Efficacy

The specificity of the mechanism of action of the drug and the features of its composition provide stable therapeutic efficacy during the period of use of the drug and the delayed effect after discontinuation of the drug (while maintaining positive dynamics towards recovery), helps to stop inflammation and reduce the risk of relapse of the disease

Rezovet's Effectiveness

Rezovet's Effectiveness

Rezovet's Effectiveness

The obtained results of the study of the use of Rezovet in production conditions give grounds for its use as an effective tool for the prevention and treatment of such bacterial infections as: hemophilosis, colibacillosis, mycoplasmosis, pasteurellosis, pullorosis, necrotic enteritis, salmonellosis and its use in the standard scheme of poultry rearing.

Stemtrix, develops innovative veterinary solutions. Trusted by major agro-complexes and poultry farms, we are committed to advancing animal health and productivity.


Invest in Stemtrix! Contact us for more details.

Stemtrix, develops innovative veterinary solutions. Trusted by major agro-complexes and poultry farms, we are committed to advancing animal health and productivity.


Invest in Stemtrix! Contact us for more details.

Stemtrix, develops innovative veterinary solutions. Trusted by major agro-complexes and poultry farms, we are committed to advancing animal health and productivity.


Invest in Stemtrix! Contact us for more details.